251 related articles for article (PubMed ID: 36674560)
21. Quantitation of ergosterol content: novel method for determination of fluconazole susceptibility of Candida albicans.
Arthington-Skaggs BA; Jradi H; Desai T; Morrison CJ
J Clin Microbiol; 1999 Oct; 37(10):3332-7. PubMed ID: 10488201
[TBL] [Abstract][Full Text] [Related]
22. [Effect of Huanglian Jiedu decoction in combination with fluconazole on ergosterol of fluconazole-resistant Candida albicans].
Yan YY; Wang TM; Shi GX; Zhang MX; Lu KQ; Shao J; Wang CZ
Zhongguo Zhong Yao Za Zhi; 2015 Feb; 40(4):727-32. PubMed ID: 26137698
[TBL] [Abstract][Full Text] [Related]
23. Efficacy of Novel Schiff base Derivatives as Antifungal Compounds in Combination with Approved Drugs Against Candida Albicans.
Malik MA; Lone SA; Gull P; Dar OA; Wani MY; Ahmad A; Hashmi AA
Med Chem; 2019; 15(6):648-658. PubMed ID: 30501599
[TBL] [Abstract][Full Text] [Related]
24. Membrane sphingolipid-ergosterol interactions are important determinants of multidrug resistance in Candida albicans.
Mukhopadhyay K; Prasad T; Saini P; Pucadyil TJ; Chattopadhyay A; Prasad R
Antimicrob Agents Chemother; 2004 May; 48(5):1778-87. PubMed ID: 15105135
[TBL] [Abstract][Full Text] [Related]
25. Candida and candidaemia. Susceptibility and epidemiology.
Arendrup MC
Dan Med J; 2013 Nov; 60(11):B4698. PubMed ID: 24192246
[TBL] [Abstract][Full Text] [Related]
26. Oxidative stress induced by piperine leads to apoptosis in Candida albicans.
Thakre A; Jadhav V; Kazi R; Shelar A; Patil R; Kharat K; Zore G; Karuppayil SM
Med Mycol; 2021 Apr; 59(4):366-378. PubMed ID: 32658959
[TBL] [Abstract][Full Text] [Related]
27. Lactate Like Fluconazole Reduces Ergosterol Content in the Plasma Membrane and Synergistically Kills
Suchodolski J; Muraszko J; Bernat P; Krasowska A
Int J Mol Sci; 2021 May; 22(10):. PubMed ID: 34069257
[No Abstract] [Full Text] [Related]
28. Increasing Susceptibility of Drug-Resistant
Sharafutdinov IS; Ozhegov GD; Sabirova AE; Novikova VV; Lisovskaya SA; Khabibrakhmanova AM; Kurbangalieva AR; Bogachev MI; Kayumov AR
Molecules; 2020 Feb; 25(3):. PubMed ID: 32024254
[TBL] [Abstract][Full Text] [Related]
29. Iranian HIV/AIDS patients with oropharyngeal candidiasis: identification, prevalence and antifungal susceptibility of Candida species.
Khedri S; Santos ALS; Roudbary M; Hadighi R; Falahati M; Farahyar S; Khoshmirsafa M; Kalantari S
Lett Appl Microbiol; 2018 Oct; 67(4):392-399. PubMed ID: 30019443
[TBL] [Abstract][Full Text] [Related]
30. Sertaconazole: a review of its use in the management of superficial mycoses in dermatology and gynaecology.
Croxtall JD; Plosker GL
Drugs; 2009; 69(3):339-59. PubMed ID: 19275277
[TBL] [Abstract][Full Text] [Related]
31. Analysis of Biofilm-Related Genes and Antifungal Susceptibility Pattern of Vaginal
Mohammadi F; Hemmat N; Bajalan Z; Javadi A
Biomed Res Int; 2021; 2021():5598907. PubMed ID: 34136569
[TBL] [Abstract][Full Text] [Related]
32. Butyl isothiocyanate exhibits antifungal and anti-biofilm activity against Candida albicans by targeting cell membrane integrity, cell cycle progression and oxidative stress.
Patil SB; Basrani ST; Chougule SA; Gavandi TC; Karuppayil SM; Jadhav AK
Arch Microbiol; 2024 May; 206(6):251. PubMed ID: 38727840
[TBL] [Abstract][Full Text] [Related]
33. Inhibition of biofilm- and hyphal- development, two virulent features of Candida albicans by secondary metabolites of an endophytic fungus Alternaria tenuissima having broad spectrum antifungal potential.
Chatterjee S; Ghosh R; Mandal NC
Microbiol Res; 2020 Feb; 232():126386. PubMed ID: 31816593
[TBL] [Abstract][Full Text] [Related]
34. Epidemiology and Antifungal Susceptibility of
Badiee P; Boekhout T; Haddadi P; Mohammadi R; Ghadimi-Moghadam A; Soltani J; Zarei Mahmoudabadi A; Ayatollahi Mousavi SA; Najafzadeh MJ; Diba K; Salimi-Khorashad AR; Amin Shahidi M; Ghasemi F; Jafarian H
Microbiol Spectr; 2022 Dec; 10(6):e0245322. PubMed ID: 36445122
[TBL] [Abstract][Full Text] [Related]
35. Riboflavin Targets the Cellular Metabolic and Ribosomal Pathways of Candida albicans
Lei J; Huang J; Xin C; Liu F; Zhang J; Xie Y; Mao Y; Chen W; Song Z
Microbiol Spectr; 2023 Feb; 11(1):e0380122. PubMed ID: 36625571
[TBL] [Abstract][Full Text] [Related]
36. Antifungal drug resistance in pathogenic fungi.
Vanden Bossche H; Dromer F; Improvisi I; Lozano-Chiu M; Rex JH; Sanglard D
Med Mycol; 1998; 36 Suppl 1():119-28. PubMed ID: 9988500
[TBL] [Abstract][Full Text] [Related]
37. In vitro and in vivo antifungal activities and mechanism of heteropolytungstates against Candida species.
Li H; Gong H; Qi Y; Li J; Ji X; Sun J; Tian R; Bao H; Song X; Chen Q; Liu G
Sci Rep; 2017 Dec; 7(1):16942. PubMed ID: 29209074
[TBL] [Abstract][Full Text] [Related]
38. Dodonaea viscosa var angustifolia derived 5,6,8-trihydroxy-7,4' dimethoxy flavone inhibits ergosterol synthesis and the production of hyphae and biofilm in Candida albicans.
Patel M; Srivastava V; Ahmad A
J Ethnopharmacol; 2020 Sep; 259():112965. PubMed ID: 32413575
[TBL] [Abstract][Full Text] [Related]
39. Resistance Surveillance in Candida albicans: A Five-Year Antifungal Susceptibility Evaluation in a Brazilian University Hospital.
Peron IH; Reichert-Lima F; Busso-Lopes AF; Nagasako CK; Lyra L; Moretti ML; Schreiber AZ
PLoS One; 2016; 11(7):e0158126. PubMed ID: 27414653
[TBL] [Abstract][Full Text] [Related]
40. Mechanism of the synergistic effect of amiodarone and fluconazole in Candida albicans.
Gamarra S; Rocha EM; Zhang YQ; Park S; Rao R; Perlin DS
Antimicrob Agents Chemother; 2010 May; 54(5):1753-61. PubMed ID: 20194694
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
